|A novel G1 checkpoint mediated by the p57 CDK inhibitor and p38 SAPK promotes cell survival upon stress.|
|Jump to Full Text|
|PMID: 22918239 Owner: NLM Status: MEDLINE|
|Comment on: Joaquin M, et al. EMBO J 2012; 31:2952-64.|
|Manel Joaquin; Albert Gubern; Francesc Posas|
Related Documents :
|20132179 - Cytopathologic differential diagnosis of small cell carcinoma and poorly differentiated...
22589549 - Anks4b, a novel target of hnf4α protein, interacts with grp78 protein and regulates en...
19961489 - Biological heterogeneity of putative bladder cancer stem-like cell populations from hum...
15375659 - Cd117 immunoreactivity in high-grade neuroendocrine tumors of the lung: a comparative s...
8909999 - Fucosyltransferase iii and sialyl-le(x) expression correlate in cultured colon carcinom...
20948309 - Ampk as a therapeutic target in renal cell carcinoma.
7645739 - Visualization of hydrogen peroxide (h2o2)-production from histamine.
8539239 - Recognition of atypical reserve cell hyperplasia in cervical smears and its diagnostic ...
6749999 - A simple rapid method for quantifying microorganisms by their metabolic activity when b...
|Type: Editorial Date: 2012-08-23|
|Title: Cell cycle (Georgetown, Tex.) Volume: 11 ISSN: 1551-4005 ISO Abbreviation: Cell Cycle Publication Date: 2012 Sep|
|Created Date: 2012-09-18 Completed Date: 2013-02-06 Revised Date: 2013-07-12|
Medline Journal Info:
|Nlm Unique ID: 101137841 Medline TA: Cell Cycle Country: United States|
|Languages: eng Pagination: 3339-40 Citation Subset: IM|
|APA/MLA Format Download EndNote Download BibTex|
Cyclin-Dependent Kinase Inhibitor p57 / metabolism*
G1 Phase Cell Cycle Checkpoints*
p38 Mitogen-Activated Protein Kinases / metabolism*
|0/Cyclin-Dependent Kinase Inhibitor p57; EC 184.108.40.206/p38 Mitogen-Activated Protein Kinases|
Journal ID (nlm-ta): Cell Cycle
Journal ID (iso-abbrev): Cell Cycle
Journal ID (publisher-id): CC
Publisher: Landes Bioscience
Copyright © 2012 Landes Bioscience
Print publication date: Day: 15 Month: 9 Year: 2012
pmc-release publication date: Day: 15 Month: 9 Year: 2012
Volume: 11 Issue: 18
First Page: 3339 Last Page: 3340
PubMed Id: 22918239
Publisher Id: 2012FT0759
Publisher Item Identifier: 21840
|A novel G1 checkpoint mediated by the p57 CDK inhibitor and p38 SAPK promotes cell survival upon stress|
|Departament de Ciències Experimentals i de la Salut; Cell Signaling Research Group; Universitat Pompeu Fabra; Barcelona, Spain
|*Correspondence to: Francesc Posas, Email: firstname.lastname@example.org
Eukaryotic cells have developed sophisticated devices to constantly monitor changes in the extracellular environment and to orchestrate a proper cellular response. Among the most conserved signaling modules throughout evolution are the mitogen-activated, protein kinase (MAPK) cascades. A prototypical family of MAPKs that respond to stress is the p38 stress-activated protein kinase (SAPK). In mammals, p38 SAPKs are activated by external stimuli, such as cytokines, infection, oxidative stress, heat shock, DNA damage and osmostress, and regulate biological processes such as immune response, inflammation, development, proliferation and survival.1 Regardless, the sensor mechanism engaged, signaling converges on p38, which will mediate an adaptive response to stress. p38 has been regarded to act as a tumor suppressor capable of controlling cell proliferation through the activation of different cell cycle checkpoints. Upon DNA damage, p38 mediates a G2/M checkpoint involving the downstream kinase MK2. MK2 phosphorylates Cdc25, which creates a docking site for 14-3-3 proteins that will retain Cdc25 into the cell cytoplasm, thus preventing Cdc2-cyclin B dephosphorylation and activation.2,3 Genotoxic stresses also contribute to G1/S arrest through the stabilization of the CDK inhibitors p21Cip1 and p27Kip1.4,5 Despite the p38 relevance on cell cycle control, the mechanisms by which this SAPK regulate cell cycle are not yet fully understood.
A recent study has shown that exposing mammalian cells to osmostress resulted in a strong G1 delay, suggesting the existence of an osmostress-regulated checkpoint.6 p38−/− cells were not able to arrest properly, indicating that this G1 checkpoint relied on p38. Cell cycle progression throughout G1 is controlled by G1 cyclin-dependent kinases (CDKs), which activity is, in turn, regulated by several CDK inhibitors (CDKis).7 In yeast, G1 progression upon osmostress by the p38/Hog1 SAPK is exerted by downregulating cyclin expression and the direct targeting of the Sic1 CDKi.8,9 In mammals, osmostress downregulated Cdk2-CyclinA/E activity in a p38-dependent manner. Therefore, p38 might be regulating CDK2 activity through the targeting of CDKis. p38 was able to directly phosphorylate the CDKi p57Kip2 at T143 both in vitro and in vivo. This particular site is located in a central region of p57 not shared by p21 or p27. Cells genetically lacking p57Kip2 failed to properly arrest at G1 upon osmostress. Osmostress-induced p57Kip2 phosphorylation neither affected its protein half-life nor its nuclear localization. Instead, p57Kip2 phosphorylation at T143 increased its protein affinity toward cyclin A/Cdk2 complexes in vitro in contrast to a non-phosphorylable p57Kip2 mutant (T143A). Altogether, CDK2 activity might be differentially regulated upon p57Kip2 phosphorylation. Indeed, p57Kip2 inhibited Cdk2-cyclin A activity in a dose-dependent manner, and this was further increased upon phosphorylation at T143. The reintroduction of wild-type p57Kip2 into p57−/− cells fully rescued the osmostress-induced G1 checkpoint and reestablished in vivo CDK2 activity regulation. Importantly, the T143A mutant was unable to fully restore the osmostress-induced G1 checkpoint and failed to regulate in vivo CDK2 activity. Therefore, p38 is regulating a novel G1 checkpoint by directly targeting the CDKi p57Kip2 (Fig. 1). Since p38 responds to a number of environmental insults, it was possible that such a G1 checkpoint might be important for proper cell adaptation to general stresses. Thus, p38−/− and p57−/− cells underwent programmed cell death after the exposure to different insults such as osmostic shock, oxidative stress and ionomycin. Notably p57−/− cell viability was rescued by reintroducing wild-type p57, but not by the T143A mutant, pointing out the biological relevance of this novel phosphorylation site to arrest cell cycle in response to stress.
Surprisingly, neither p21 nor p27 compensated for the lack of p57. Although p21 was found to be upregulated in the absence of p57, it was unable to regulate the G1 phase and cell viability upon stress. Additionally, p27−/− cell viability was not compromised upon cell stress, indicating that p57 is just enough to integrate a broad range of cell stresses in a p38-dependent manner. Both p21 and p27 are p38 targets. Then, why do these CDKs not contribute to cell survival? One explanation would be the type of stress. UV and DNA damaging agents activate the p53, ATM/ATR as well as the p38 SAPK pathways, resulting in the regulation of both p21 and p27. In that scenario, p57 is not relevant, since UV-induced DNA damage did not affect p57−/− viability but strongly compromised p38−/− cell fitness. Also, downregulation of p38 substrates such as Cdt1 and MK2, which are involved in controlling S-phase and G2/M checkpoints, respectively, do not contribute to cell survival upon stress.2,3,10
Altogether, p38 and p57 impose a G1 cell cycle arrest to promote cell survival upon cell stresses. But why is so important to delay G1 cell cycle progression? We may speculate that to build up a proper cell adaptation response, cells need time to upregulate a specific set of genes. Indeed, stress-induced p38 controls the expression of many genes involved in cell proliferation as well as cell survival in a time-dependent manner.11 The relationship between cell cycle control and gene expression regulation has not been studied thoroughly, but delaying G1 progression might be a step necessary to upregulate the essential genes needed for cell adaptation before progressing into S phase.
Previously published online: www.landesbioscience.com/journals/cc/article/21840
|1.||Cuadrado A,et al. Biochem JYear: 20104294031710.1042/BJ2010032320626350|
|2.||Manke IA,et al. Mol CellYear: 200517374810.1016/j.molcel.2004.11.02115629715|
|3.||Reinhardt HC,et al. Cancer CellYear: 2007111758910.1016/j.ccr.2006.11.02417292828|
|4.||Cuadrado M,et al. Cancer ResYear: 20096987263210.1158/0008-5472.CAN-09-072919843869|
|5.||Lafarga V,et al. Mol Cell BiolYear: 20092943415110.1128/MCB.00210-0919528229|
|6.||Joaquin M,et al. EMBO JYear: 20123129526410.1038/emboj.2012.12222569127|
|7.||Besson A,et al. Dev CellYear: 2008141596910.1016/j.devcel.2008.01.01318267085|
|8.||Escoté X,et al. Nat Cell BiolYear: 20046997100210.1038/ncb117415448699|
|9.||Adrover MÀ,et al. Sci SignalYear: 20114ra6310.1126/scisignal.200220421954289|
|10.||Chandrasekaran S,et al. Mol Cell BiolYear: 20113144051610.1128/MCB.06163-1121930785|
|11.||Ferreiro I,et al. BMC GenomicsYear: 20101114410.1186/1471-2164-11-14420187982|
Keywords: Keywords: cell cycle, cell stress, cell survival, p38 SAPK, p57 CDKi.
Previous Document: Convergent signaling in the regulation of connective tissue growth factor in malignant mesothelioma:...
Next Document: TOR under stress: targeting TORC1 by Rho1 GTPase.